Literature DB >> 30085011

Hepatitis C prevalence and associated risk factors among individuals who are homeless and diagnosed with mental illness: At Home/Chez Soi Study, Vancouver, BC.

Nooshin Nikoo1,2,3,4, Sanam Javidanbardan1,3,4, Moniruzzaman Akm5, Syune Hakobyan1,6, Mohammadali Nikoo1,7, Celia Kwan1,4, Michael Song1,4, Marc Vogel1,8, Julian Somers5, Michael Krausz1,3,4,7.   

Abstract

BACKGROUND: There is scarce evidence on prevalence of hepatitis C virus (HCV) infection among individuals who are homeless and diagnosed with severe mental illness. We aimed to investigate the prevalence of HCV infection and associated risk factors in a representative sample of adults from At Home study.
METHODS: The Vancouver At Home study is part of the At Home/Chez Soi (AH/CS) project-a pragmatic randomized controlled trial of a Housing First intervention among homeless persons with mental illness in five Canadian cities between 2009 and 2013 with a 2-year follow-up period.
RESULTS: Of 497 participants, 28% reported positive HCV serostatus. Educational level equal or less than eighth grade (AOR: 2.3, 95% CI: 1.1, 4.8), history of incarceration (AOR: 2.1, 95% CI: 1.2, 3.5), substance dependence (AOR: 2.0, 95% CI: 1.1, 3.7) and injection drug use during one month prior to the recruitment (AOR: 7.8, 95% CI: 4.0, 15.0) were associated with an increased risk of HCV infection. Having a psychotic disorder (AOR: 0.6, 95% CI: 0.3, 1.0) and age < 25 (AOR: 0.2, 95% CI: 0.0, 0.7) were associated with a lower risk. Blood tests performed on 30 participants agreed with self-report in 97% of cases [Kappa = 0.9 (95% CI: 0.6, 1.3), PABAK = 0.9].
CONCLUSION: The high prevalence of HCV among individuals who were homeless with mental illness underlies the importance of prevention and treatment of HCV in this population, especially those with concurrent substance use disorders. Self-report seems to be a valid tool for evaluation of the HCV status in this population.
© The Author(s) 2018. Published by Oxford University Press on behalf of the European Public Health Association. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 30085011     DOI: 10.1093/eurpub/cky142

Source DB:  PubMed          Journal:  Eur J Public Health        ISSN: 1101-1262            Impact factor:   3.367


  4 in total

1.  Predictors of hepatitis C treatment outcomes in a harm reduction-focused primary care program in New York City.

Authors:  Jacob Ziff; Trang Vu; Danielle Dvir; Farah Riazi; Wilma Toribio; Scott Oster; Keith Sigel; Jeffrey Weiss
Journal:  Harm Reduct J       Date:  2021-03-31

2.  Study protocol: a randomised, controlled trial of a nurse navigator program for the management of hepatitis C virus in patients with severe mental disorder.

Authors:  Casta Quemada-González; José Miguel Morales-Asencio; María M Hurtado; Celia Martí-García
Journal:  BMC Nurs       Date:  2022-04-20

3.  The Impact of Supportive Housing on Liver-Related Outcomes Among Persons With Hepatitis C Virus Infection.

Authors:  Sara A Miller-Archie; Sarah C Walters; Angelica Bocour; Miranda S Moore; Ellen Wiewel; Tejinder Singh; Sungwoo Lim
Journal:  J Infect Dis       Date:  2022-10-07       Impact factor: 7.759

4.  Hepatitis C Screening Among Medicaid Patients With Schizophrenia, 2002-2012.

Authors:  Marilyn D Thomas; Eric Vittinghoff; Stephen Crystal; James Walkup; Mark Olfson; Mandana Khalili; Priya Dahiya; Walker Keenan; Francine Cournos; Christina Mangurian
Journal:  Schizophr Bull Open       Date:  2022-01-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.